Analytical Data
-
Gene name
Ccl7
- Application
-
Alternative Names
Ccl7；MCP3；SCYA6；SCYA7；C-C motif chemokine 7
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P80098
-
Expression Region
24-99aa
-
AA Sequence
QPVGINTSTT CCYRFINKKI PKQRLESYRR TTSSHCPREA VIFKTKLDKE ICADPTQKWV QDFMKHLDKK TQTPKL
-
Molecular Weight
9.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Ccl7, also known as chemokine (C-C motif) ligand 7, is a crucial member of the chemokine family that plays a significant role in immune responses and inflammation. Research on Ccl7 has gained traction due to its involvement in the recruitment of immune cells, particularly monocytes and T cells, to sites of inflammation, which is vital in various pathophysiological conditions such as infection, autoimmune disorders, and cancer. The recombinant protein form of Ccl7 has been extensively studied for its potential applications in therapeutics and diagnostics. By producing Ccl7 in a recombinant form, researchers are able to investigate its biological functions, mechanisms of action, and interactions with chemokine receptors. This recombinant protein also serves as a valuable tool for studying inflammatory processes and the immune system's architecture. Additionally, Ccl7's role in tumor microenvironments has attracted interest in cancer research; understanding its signaling pathways could lead to novel strategies for immunotherapy. Furthermore, as Ccl7 is involved in various diseases, the development of Ccl7 inhibitors might offer new avenues for treatment. Overall, the study of Ccl7 recombinant protein not only enhances our understanding of immune mechanisms but also represents a promising area for the development of new therapeutic strategies. As research in this field advances, it holds the potential to contribute significantly to the management of diseases marked by dysregulated inflammation and immune responses.
